The 2022 ESCMID/ASM Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance will take place in Dublin, Ireland on October 4-7, 2022. Make sure to save the date.

Antimicrobial drug resistance (AMR) is an urgent global health problem. New antimicrobial drug development is increasingly viewed as a priority by national and international bodies. Co-sponsored by the American Society for Microbiology (ASM) and the European Society for Clinical Microbiology and Infectious Diseases (ESCMID), this multidisciplinary meeting will address the challenges, opportunities and current requirements for antimicrobial drug development to address antimicrobial resistance.

Dr. Erin Duffy, CARB-X Chief of R&D, will be presenting on preclinical development of non-traditional/novel classes during Symposium 7.